Dasatinib Accordpharma Liên Minh Châu Âu - Tiếng Iceland - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Æxlishemjandi lyf - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Cipramil Filmuhúðuð tafla 20 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

cipramil filmuhúðuð tafla 20 mg

h. lundbeck a/s* - citalopram hydrobromide - filmuhúðuð tafla - 20 mg

Cipramil Filmuhúðuð tafla 10 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

cipramil filmuhúðuð tafla 10 mg

h. lundbeck a/s* - citalopram hydrobromide - filmuhúðuð tafla - 10 mg

Venlafaxin Medical Valley Forðatafla 150 mg Iceland - Tiếng Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

venlafaxin medical valley forðatafla 150 mg

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg